Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility

Sponsor
Columbia University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04949711
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH)
7,560
1
2
44.9
168.2

Study Details

Study Description

Brief Summary

The purpose of this research study is to understand people's alcohol use in public places and their risks for harm. The overall goal of this study is to test the effects of subsidized ridesharing as an intervention to reduce self-reported alcohol-impaired driving, along with alcohol consumption and changes to mobility.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ridesharing voucher
  • Behavioral: online shopping voucher
N/A

Detailed Description

Motor vehicle crashes are the leading cause of death for people aged 13-25 years in the US, and approximately 31% of all fatal crashes involved some alcohol use. Several peer-reviewed studies have found that ridesharing was associated with fewer alcohol-involved crashes and DUI arrests. Theories of behavioral economics provide a clear theoretical mechanism by which ridesharing will reduce alcohol-involved motor vehicle crashes compared to other private transportation. However, while ridesharing may be an effective intervention to reduce alcohol-involved crashes, it may simultaneously increase alcohol consumption. This study will assess the impacts of subsidized ridesharing on impaired driving, alcohol consumption, and mobility. Participants will be randomized to either receive a rideshare voucher or an online shopping voucher, and effects on alcohol impaired driving and alcohol consumption will be measured. A GPS sub-group will use a custom smartphone application for GPS tracking to measure mobility.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
7560 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Apr 30, 2026
Anticipated Study Completion Date :
Apr 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Participants will be asked to complete 3 surveys over 2 weeks to collect in information on their alcohol use and about themselves, and receive ridesharing vouchers.

Behavioral: ridesharing voucher
Ridesharing vouchers will be given for completing each of the online surveys, for a possible total of $80 if you complete all three surveys. You will be paid with electronic vouchers that will be sent to your cell phone.
Other Names:
  • Uber voucher
  • Sham Comparator: Control

    Participants will be asked to complete 3 surveys over 2 weeks to collect in information on their alcohol use and about themselves, and receive online shopping voucher.

    Behavioral: online shopping voucher
    Online shopping vouchers will be given for completing each of the online surveys, for a possible total of $80 if you complete all three surveys. You will be paid with electronic vouchers that will be sent to your cell phone.
    Other Names:
  • Amazon voucher
  • Outcome Measures

    Primary Outcome Measures

    1. Change in the alcohol impaired driving incidents [Baseline, 1 week follow-up, 2 week follow-up]

      Participants will provide two self-reported measures of impaired driving by indicating whether they "drove after drinking any alcohol" (driving after drinking) and "drove after drinking too much alcohol to drive safely" (driving while intoxicated) for each day during the previous 7 days.

    Secondary Outcome Measures

    1. Change in number of days in alcohol consumption [Baseline, 1 week follow-up, 2 week follow-up]

      Participants will be asked to state the number of drinks consumed on each day for the 7 previous days, and their responses will be used to calculate the frequency (defined as the number of drinking days) and the continued volume (defined as total number of drinks consumed after 1 drink on a drinking day) of drinking.

    2. Average frequency of trips to alcohol outlets [Day 3 to Day 17 of study]

      Participants enrolled in the GPS sub-sample will be tracked and GPS records will be used measure exposure to alcohol outlets and mobility.

    3. Average duration of trips to alcohol outlets [Day 3 to Day 17 of study]

      Participants enrolled in the GPS sub-sample will be tracked and GPS records will be used measure exposure to alcohol outlets and mobility.

    4. Change in The Drinker Inventory of Consequences Score [Baseline, 1 week follow-up, 2 week follow-up]

      The Drinker Inventory of Consequences is a 45-item measure of alcohol-related consequences on which higher scores reflect greater alcohol consequences. It measures harms related to alcohol consumption within 5 sub-scales: physical consequences, intrapersonal consequences, social responsibility consequences, interpersonal consequences, and impulse control consequences.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • ≥ 21 years old

    • Reside in a study city

    • Have a driver's license

    • Have access to a motor vehicle

    • Have consumed alcohol in a bar in the last 30 days

    • Own a smartphone

    • Read English

    Exclusion Criteria:
    • Non-English speaking participants

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Columbia University Irving Medical Center New York New York United States 10032

    Sponsors and Collaborators

    • Columbia University
    • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    Investigators

    • Principal Investigator: Christopher Morrison, PhD, Columbia University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Christopher Morrison, Assistant Professor of Epidemiology, Columbia University
    ClinicalTrials.gov Identifier:
    NCT04949711
    Other Study ID Numbers:
    • AAAT0912
    • 1R01AA029112-01
    First Posted:
    Jul 2, 2021
    Last Update Posted:
    Jul 21, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Christopher Morrison, Assistant Professor of Epidemiology, Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 21, 2022